Cure My Disease

Don't miss your cure!

 Log in / Sign up

Patients helping patients: a new test for depression care

NCT ID NCT06398561

Disease control Sponsor: University of the Balearic Islands Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether a peer-led support program, where trained patients guide group sessions, can reduce depressive symptoms in adults with major depression. Researchers in Mallorca will compare this approach to an online mental health app. About 70 participants from primary care mental health units will take part, and their depression levels will be measured over 12 months. The goal is to see if peer support can be a useful addition to standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Peer-led group training program (Active Patient Program) where trained patients lead sessions to support others with major depression
What this could lead to
If it works, peer-led group support could become a low-cost addition to standard depression care, helping more people manage symptoms without extra medication.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply broadly. The outcome depends on how well peer leaders are trained and how engaged participants remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

81 people

The number who actually took part.

Started

May 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Selection and withdrawal of subjects Inclusion criteria: * People over 18 years of age. * Attending consultations with any of the professionals in the USM mental health network. * Having an active diagnostic label of Major Depressive Disorder, according to ICD or DSM criteria in the Primary Care e-SIAP program or meeting MINI TRAS criteria after individual interview for Major Depressive Episode. Exclusion criteria * People who present mental health disorders associated with a depressive disorder and who are in the acute phase of the disease. * People who are not under active follow-up with any of the professionals of the USM. * People with mobility problems and / or displacement to the health center. * People suffering from another disease affecting the CNS (organic brain pathology or who have suffered a severe head injury, onset dementia or any other neurodegenerative disease, etc.). * People with presence of uncontrolled serious medical, infectious or degenerative disease, which may interfere with affective symptomatology. * People with significant risk of suicide according to medical criteria, assessed through follow-up interviews conducted by mental health professionals of reference. * People with any medical, psychological and/or social problem that could seriously interfere with the patient's participation in the study. * People who are legally incapacitated to make health decisions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depressive disorder, major are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression Health Education major depressive disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Depressive disorder, major

Contacts and locations

Locations

  • Xandra González García

    Palma de Mallorca, Balearic Islands, 07122, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.